SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-19-000058
Filing Date
2019-04-11
Accepted
2019-04-11 17:16:31
Documents
8
Period of Report
2019-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm8-kpipe.htm 8-K 45853
2 EXHIBIT 4.1 exhibit41-formofwarrant.htm EX-4.1 83184
3 EXHIBIT 4.2 exhibit42-formofwarrantfor.htm EX-4.2 85807
4 EXHIBIT 9.1 exhibit91-pdlvotingagreeme.htm EX-9.1 57893
5 EXHIBIT 10.1 exhibit101-pdlsecuritiespu.htm EX-10.1 333946
6 EXHIBIT 10.2 exhibit102-pdlregistration.htm EX-10.2 140817
7 EXHIBIT 99.1 exhibit991-pressreleasepipe.htm EX-99.1 15564
8 evofembiosciencesjpegfilea04.jpg GRAPHIC 61097
  Complete submission text file 0001618835-19-000058.txt   848661
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 19744449
SIC: 2834 Pharmaceutical Preparations